472 related articles for article (PubMed ID: 20518580)
1. Pharmacotherapy for hepatic encephalopathy.
Phongsamran PV; Kim JW; Cupo Abbott J; Rosenblatt A
Drugs; 2010 Jun; 70(9):1131-48. PubMed ID: 20518580
[TBL] [Abstract][Full Text] [Related]
2. Disaccharides in the treatment of hepatic encephalopathy.
Sharma P; Sharma BC
Metab Brain Dis; 2013 Jun; 28(2):313-20. PubMed ID: 23456517
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.
Zacharias HD; Zacharias AP; Gluud LL; Morgan MY
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012334. PubMed ID: 31204790
[TBL] [Abstract][Full Text] [Related]
4. Management of overt hepatic encephalopathy.
Sharma P; Sharma BC
J Clin Exp Hepatol; 2015 Mar; 5(Suppl 1):S82-7. PubMed ID: 26041964
[TBL] [Abstract][Full Text] [Related]
5. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Gluud LL; Vilstrup H; Morgan MY
Cochrane Database Syst Rev; 2016 May; 2016(5):CD003044. PubMed ID: 27153247
[TBL] [Abstract][Full Text] [Related]
6. Management of Hepatic Encephalopathy: A Primer.
Jawaro T; Yang A; Dixit D; Bridgeman MB
Ann Pharmacother; 2016 Jul; 50(7):569-77. PubMed ID: 27126547
[TBL] [Abstract][Full Text] [Related]
7. Management of hepatic encephalopathy in the hospital.
Leise MD; Poterucha JJ; Kamath PS; Kim WR
Mayo Clin Proc; 2014 Feb; 89(2):241-53. PubMed ID: 24411831
[TBL] [Abstract][Full Text] [Related]
8. Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?
Gluud LL; Dam G; Borre M; Les I; Cordoba J; Marchesini G; Aagaard NK; Vilstrup H
Metab Brain Dis; 2013 Jun; 28(2):221-5. PubMed ID: 23275147
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy for the treatment and prevention of hepatic encephalopathy.
Mohammad RA; Regal RE; Alaniz C
Ann Pharmacother; 2012 Nov; 46(11):1559-63. PubMed ID: 23092866
[TBL] [Abstract][Full Text] [Related]
10. Management of hepatic encephalopathy: focus on antibiotic therapy.
Festi D; Vestito A; Mazzella G; Roda E; Colecchia A
Digestion; 2006; 73 Suppl 1():94-101. PubMed ID: 16498257
[TBL] [Abstract][Full Text] [Related]
11. Rifaximin for the treatment of hepatic encephalopathy.
de Melo RT; Charneski L; Hilas O
Am J Health Syst Pharm; 2008 May; 65(9):818-22. PubMed ID: 18436728
[TBL] [Abstract][Full Text] [Related]
12. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.
Gluud LL; Vilstrup H; Morgan MY
Cochrane Database Syst Rev; 2016 Apr; 4():CD003044. PubMed ID: 27089005
[TBL] [Abstract][Full Text] [Related]
13. Hepatic encephalopathy - recent advances in treatment and diagnosis.
Nardelli S; Gioia S; Faccioli J; Riggio O; Ridola L
Expert Rev Gastroenterol Hepatol; 2023 Mar; 17(3):225-235. PubMed ID: 36843291
[TBL] [Abstract][Full Text] [Related]
14. Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy.
Zhu GQ; Shi KQ; Huang S; Wang LR; Lin YQ; Huang GQ; Chen YP; Braddock M; Zheng MH
Aliment Pharmacol Ther; 2015 Apr; 41(7):624-35. PubMed ID: 25684317
[TBL] [Abstract][Full Text] [Related]
15. Rifaximin for treatment of hepatic encephalopathy.
Maclayton DO; Eaton-Maxwell A
Ann Pharmacother; 2009 Jan; 43(1):77-84. PubMed ID: 19092143
[TBL] [Abstract][Full Text] [Related]
16. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
Prakash RK; Kanna S; Mullen KD
Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostics and treatment of hepatic encephalopathy].
Gillmann A; Gerharz CD; Müssig K
Dtsch Med Wochenschr; 2012 Jan; 137(1-2):29-33. PubMed ID: 22180281
[TBL] [Abstract][Full Text] [Related]
18. Hepatic encephalopathy: pathophysiology and emerging therapies.
Sundaram V; Shaikh OS
Med Clin North Am; 2009 Jul; 93(4):819-36, vii. PubMed ID: 19577116
[TBL] [Abstract][Full Text] [Related]
19. Review article: the current pharmacological therapies for hepatic encephalopathy.
Bass NM
Aliment Pharmacol Ther; 2007 Feb; 25 Suppl 1():23-31. PubMed ID: 17295849
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy.
Ahire K; Sonawale A
J Assoc Physicians India; 2017 Aug; 65(8):42-46. PubMed ID: 28799305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
